Free US stock valuation multiples and PEG ratio analysis to identify reasonably priced growth companies. Our valuation framework helps you find stocks with the right balance of growth and value characteristics.
As of April 6, 2026, Evogene Ltd Ordinary Shares (EVGN) trades at $0.78, marking a minor 0.15% decline in the current session. This analysis evaluates recent trading trends, key technical levels, and potential near-term scenarios for the biotech stock, with no investment recommendations included. No recent earnings data is available for EVGN at the time of writing, so price action in recent weeks has been driven primarily by broader market sentiment and sector flows rather than company-specific
Is Evogene (EVGN) Stock a Safe Investment | Price at $0.78, Down 0.15% - Profit Potential
EVGN - Stock Analysis
4332 Comments
1221 Likes
1
Jensin
Experienced Member
2 hours ago
Access real-time US stock market data with expert analysis and strategic recommendations focused on building a balanced and profitable portfolio. We help you diversify across sectors and industries to minimize concentration risk while maximizing growth potential.
👍 67
Reply
2
Renzo
Active Reader
5 hours ago
Price action remains choppy, with intraday fluctuations reflecting a mix of buying and selling pressure.
👍 294
Reply
3
Aakeem
Power User
1 day ago
How are you not famous yet? 🌟
👍 24
Reply
4
Fray
Experienced Member
1 day ago
Real-time US stock event calendar and catalyst tracking for understanding upcoming market-moving announcements. Our event calendar helps you prepare for earnings releases, product launches, and other important dates.
👍 97
Reply
5
Kalif
Active Contributor
2 days ago
My brain said yes but my soul said wait.
👍 167
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.